Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience
Our aim is to evaluate the frequency and characteristics of cancer in the population of patients with solid organ transplant who are under immunosuppressive medication. In this study we aimed to emphasize the importance of early diagnosis of cancer in solid organ transplant recipients. An aging popu...
Gespeichert in:
Veröffentlicht in: | The Eurasian journal of medicine 2016-02, Vol.48 (1), p.33-36 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 36 |
---|---|
container_issue | 1 |
container_start_page | 33 |
container_title | The Eurasian journal of medicine |
container_volume | 48 |
creator | Turkeli, Mehmet Simsek, Melih Aldemir, Mehmet Naci Yildirim, Nilgun Cankaya, Erdem Erdemci, Burak Bilici, Mehmet Tekin, Salim Basol Arslan, Sukru Korkut, Ercan |
description | Our aim is to evaluate the frequency and characteristics of cancer in the population of patients with solid organ transplant who are under immunosuppressive medication. In this study we aimed to emphasize the importance of early diagnosis of cancer in solid organ transplant recipients. An aging population began to receive solid organ transplantation and survival times prolonged. But this had a cost and new problems came forward. Especially de novo cancers because of immunosuppressive therapy took notice. Risk of malignancy increases after organ transplantation and cancer incidence was about 2.3-3.1% in these patients including skin cancer, lung cancer, malign lymphoma, cervix cancer, kaposi sarcoma, and hepatobiliary cancer.
The files of 328 organ transplant recipients followed from January 2004 to April 2015 at Atatürk University Medical Faculty were retrospectively reviewed.
Eight patients developed cancer (2.4%). There were six males and two females. Age at cancer diagnosis ranged from 42 to 79 years old with average of 55 years. The interval from solid organ transplantation to cancer diagnosis ranged from 6 months to 30 years. Among the patients, five were renal transplant recipients and two were liver transplant recipients. Four patients had stage IV disease, one patient stage IIIB, and three patients had stage I disease. For none of the patients a diagnosis with screening methods was used for cancer before any complaints of tumor emerged.
To diagnose cancer at early stages in solid organ transplant recipients, earlier and detailed cancer screening is very important. The association between diagnosis of cancer at early stages and prolonged overall survival time is well known. Detailed and careful evaluation for occult malignancies in pre-transplantation period is also important. |
doi_str_mv | 10.5152/eurasianjmed.2015.0087 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4792494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1777488022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-2aa2ecade8e3c267796788543c26bee3df5df6c276c6fc34591e8a95bf4fa4b13</originalsourceid><addsrcrecordid>eNpdkV1rFDEUhoMottT-hRLwQm92zddMMjdKqfUDtqxgRbwKZzNnpllmkzWZKfXfm6F1qc1NcpLnvLwnLyFnnC0rXol3OCXIHsJ2h-1SMF4tGTP6GTnmkpmF0Uo8P5ylOiKnOW9ZWaqRUtQvyZHQTNS6FscknCekP5GuYETqAx1vkH700IeYfaaxo1cw-D740WOma-emlHzoZ_J7HHxL16mHQK8ThLwfIIz0GxQ0jPkD5Zz-Qkj5Db2822Mqtw5fkRcdDBlPH_YT8uPT5fXFl8Vq_fnrxflq4aRpxoUAEOigRYPSFae6qbUxlZqLDaJsu6rtaid07erOSVU1HA001aZTHagNlyfk_b3uftqUT3LFUYLB7pPfQfpjI3j7_0vwN7aPt1bpRqhGFYG3DwIp_p4wj3bns8OhzIhxypZrrZUxTIiCvn6CbuOUQhnPcqMrWeLQM1XfUy7FnBN2BzOc2TlV-zhVO6dq51RL49njUQ5t_zKUfwHEVqKB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875374272</pqid></control><display><type>article</type><title>Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Turkeli, Mehmet ; Simsek, Melih ; Aldemir, Mehmet Naci ; Yildirim, Nilgun ; Cankaya, Erdem ; Erdemci, Burak ; Bilici, Mehmet ; Tekin, Salim Basol ; Arslan, Sukru ; Korkut, Ercan</creator><creatorcontrib>Turkeli, Mehmet ; Simsek, Melih ; Aldemir, Mehmet Naci ; Yildirim, Nilgun ; Cankaya, Erdem ; Erdemci, Burak ; Bilici, Mehmet ; Tekin, Salim Basol ; Arslan, Sukru ; Korkut, Ercan</creatorcontrib><description>Our aim is to evaluate the frequency and characteristics of cancer in the population of patients with solid organ transplant who are under immunosuppressive medication. In this study we aimed to emphasize the importance of early diagnosis of cancer in solid organ transplant recipients. An aging population began to receive solid organ transplantation and survival times prolonged. But this had a cost and new problems came forward. Especially de novo cancers because of immunosuppressive therapy took notice. Risk of malignancy increases after organ transplantation and cancer incidence was about 2.3-3.1% in these patients including skin cancer, lung cancer, malign lymphoma, cervix cancer, kaposi sarcoma, and hepatobiliary cancer.
The files of 328 organ transplant recipients followed from January 2004 to April 2015 at Atatürk University Medical Faculty were retrospectively reviewed.
Eight patients developed cancer (2.4%). There were six males and two females. Age at cancer diagnosis ranged from 42 to 79 years old with average of 55 years. The interval from solid organ transplantation to cancer diagnosis ranged from 6 months to 30 years. Among the patients, five were renal transplant recipients and two were liver transplant recipients. Four patients had stage IV disease, one patient stage IIIB, and three patients had stage I disease. For none of the patients a diagnosis with screening methods was used for cancer before any complaints of tumor emerged.
To diagnose cancer at early stages in solid organ transplant recipients, earlier and detailed cancer screening is very important. The association between diagnosis of cancer at early stages and prolonged overall survival time is well known. Detailed and careful evaluation for occult malignancies in pre-transplantation period is also important.</description><identifier>ISSN: 1308-8734</identifier><identifier>EISSN: 1308-8742</identifier><identifier>DOI: 10.5152/eurasianjmed.2015.0087</identifier><identifier>PMID: 27026762</identifier><language>eng</language><publisher>Turkey: Galenos Publishing House</publisher><subject>Original</subject><ispartof>The Eurasian journal of medicine, 2016-02, Vol.48 (1), p.33-36</ispartof><rights>Copyright Aves Yayincilik Ltd. STI. Feb 2016</rights><rights>Copyright 2016 by the Atatürk University School of Medicine - Available online at 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792494/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792494/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27026762$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Turkeli, Mehmet</creatorcontrib><creatorcontrib>Simsek, Melih</creatorcontrib><creatorcontrib>Aldemir, Mehmet Naci</creatorcontrib><creatorcontrib>Yildirim, Nilgun</creatorcontrib><creatorcontrib>Cankaya, Erdem</creatorcontrib><creatorcontrib>Erdemci, Burak</creatorcontrib><creatorcontrib>Bilici, Mehmet</creatorcontrib><creatorcontrib>Tekin, Salim Basol</creatorcontrib><creatorcontrib>Arslan, Sukru</creatorcontrib><creatorcontrib>Korkut, Ercan</creatorcontrib><title>Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience</title><title>The Eurasian journal of medicine</title><addtitle>Eurasian J Med</addtitle><description>Our aim is to evaluate the frequency and characteristics of cancer in the population of patients with solid organ transplant who are under immunosuppressive medication. In this study we aimed to emphasize the importance of early diagnosis of cancer in solid organ transplant recipients. An aging population began to receive solid organ transplantation and survival times prolonged. But this had a cost and new problems came forward. Especially de novo cancers because of immunosuppressive therapy took notice. Risk of malignancy increases after organ transplantation and cancer incidence was about 2.3-3.1% in these patients including skin cancer, lung cancer, malign lymphoma, cervix cancer, kaposi sarcoma, and hepatobiliary cancer.
The files of 328 organ transplant recipients followed from January 2004 to April 2015 at Atatürk University Medical Faculty were retrospectively reviewed.
Eight patients developed cancer (2.4%). There were six males and two females. Age at cancer diagnosis ranged from 42 to 79 years old with average of 55 years. The interval from solid organ transplantation to cancer diagnosis ranged from 6 months to 30 years. Among the patients, five were renal transplant recipients and two were liver transplant recipients. Four patients had stage IV disease, one patient stage IIIB, and three patients had stage I disease. For none of the patients a diagnosis with screening methods was used for cancer before any complaints of tumor emerged.
To diagnose cancer at early stages in solid organ transplant recipients, earlier and detailed cancer screening is very important. The association between diagnosis of cancer at early stages and prolonged overall survival time is well known. Detailed and careful evaluation for occult malignancies in pre-transplantation period is also important.</description><subject>Original</subject><issn>1308-8734</issn><issn>1308-8742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkV1rFDEUhoMottT-hRLwQm92zddMMjdKqfUDtqxgRbwKZzNnpllmkzWZKfXfm6F1qc1NcpLnvLwnLyFnnC0rXol3OCXIHsJ2h-1SMF4tGTP6GTnmkpmF0Uo8P5ylOiKnOW9ZWaqRUtQvyZHQTNS6FscknCekP5GuYETqAx1vkH700IeYfaaxo1cw-D740WOma-emlHzoZ_J7HHxL16mHQK8ThLwfIIz0GxQ0jPkD5Zz-Qkj5Db2822Mqtw5fkRcdDBlPH_YT8uPT5fXFl8Vq_fnrxflq4aRpxoUAEOigRYPSFae6qbUxlZqLDaJsu6rtaid07erOSVU1HA001aZTHagNlyfk_b3uftqUT3LFUYLB7pPfQfpjI3j7_0vwN7aPt1bpRqhGFYG3DwIp_p4wj3bns8OhzIhxypZrrZUxTIiCvn6CbuOUQhnPcqMrWeLQM1XfUy7FnBN2BzOc2TlV-zhVO6dq51RL49njUQ5t_zKUfwHEVqKB</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Turkeli, Mehmet</creator><creator>Simsek, Melih</creator><creator>Aldemir, Mehmet Naci</creator><creator>Yildirim, Nilgun</creator><creator>Cankaya, Erdem</creator><creator>Erdemci, Burak</creator><creator>Bilici, Mehmet</creator><creator>Tekin, Salim Basol</creator><creator>Arslan, Sukru</creator><creator>Korkut, Ercan</creator><general>Galenos Publishing House</general><general>The Eurasian Journal of Medicine</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>U9A</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160201</creationdate><title>Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience</title><author>Turkeli, Mehmet ; Simsek, Melih ; Aldemir, Mehmet Naci ; Yildirim, Nilgun ; Cankaya, Erdem ; Erdemci, Burak ; Bilici, Mehmet ; Tekin, Salim Basol ; Arslan, Sukru ; Korkut, Ercan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-2aa2ecade8e3c267796788543c26bee3df5df6c276c6fc34591e8a95bf4fa4b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Turkeli, Mehmet</creatorcontrib><creatorcontrib>Simsek, Melih</creatorcontrib><creatorcontrib>Aldemir, Mehmet Naci</creatorcontrib><creatorcontrib>Yildirim, Nilgun</creatorcontrib><creatorcontrib>Cankaya, Erdem</creatorcontrib><creatorcontrib>Erdemci, Burak</creatorcontrib><creatorcontrib>Bilici, Mehmet</creatorcontrib><creatorcontrib>Tekin, Salim Basol</creatorcontrib><creatorcontrib>Arslan, Sukru</creatorcontrib><creatorcontrib>Korkut, Ercan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career & Technical Education Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Eurasian journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Turkeli, Mehmet</au><au>Simsek, Melih</au><au>Aldemir, Mehmet Naci</au><au>Yildirim, Nilgun</au><au>Cankaya, Erdem</au><au>Erdemci, Burak</au><au>Bilici, Mehmet</au><au>Tekin, Salim Basol</au><au>Arslan, Sukru</au><au>Korkut, Ercan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience</atitle><jtitle>The Eurasian journal of medicine</jtitle><addtitle>Eurasian J Med</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>48</volume><issue>1</issue><spage>33</spage><epage>36</epage><pages>33-36</pages><issn>1308-8734</issn><eissn>1308-8742</eissn><abstract>Our aim is to evaluate the frequency and characteristics of cancer in the population of patients with solid organ transplant who are under immunosuppressive medication. In this study we aimed to emphasize the importance of early diagnosis of cancer in solid organ transplant recipients. An aging population began to receive solid organ transplantation and survival times prolonged. But this had a cost and new problems came forward. Especially de novo cancers because of immunosuppressive therapy took notice. Risk of malignancy increases after organ transplantation and cancer incidence was about 2.3-3.1% in these patients including skin cancer, lung cancer, malign lymphoma, cervix cancer, kaposi sarcoma, and hepatobiliary cancer.
The files of 328 organ transplant recipients followed from January 2004 to April 2015 at Atatürk University Medical Faculty were retrospectively reviewed.
Eight patients developed cancer (2.4%). There were six males and two females. Age at cancer diagnosis ranged from 42 to 79 years old with average of 55 years. The interval from solid organ transplantation to cancer diagnosis ranged from 6 months to 30 years. Among the patients, five were renal transplant recipients and two were liver transplant recipients. Four patients had stage IV disease, one patient stage IIIB, and three patients had stage I disease. For none of the patients a diagnosis with screening methods was used for cancer before any complaints of tumor emerged.
To diagnose cancer at early stages in solid organ transplant recipients, earlier and detailed cancer screening is very important. The association between diagnosis of cancer at early stages and prolonged overall survival time is well known. Detailed and careful evaluation for occult malignancies in pre-transplantation period is also important.</abstract><cop>Turkey</cop><pub>Galenos Publishing House</pub><pmid>27026762</pmid><doi>10.5152/eurasianjmed.2015.0087</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1308-8734 |
ispartof | The Eurasian journal of medicine, 2016-02, Vol.48 (1), p.33-36 |
issn | 1308-8734 1308-8742 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4792494 |
source | DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Original |
title | Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T19%3A09%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20We%20Late%20in%20the%20Diagnosis%20of%20Malignities%20Occurring%20in%20Solid%20Organ%20Transplant%20Patients?%2011%20Years'%20Experience&rft.jtitle=The%20Eurasian%20journal%20of%20medicine&rft.au=Turkeli,%20Mehmet&rft.date=2016-02-01&rft.volume=48&rft.issue=1&rft.spage=33&rft.epage=36&rft.pages=33-36&rft.issn=1308-8734&rft.eissn=1308-8742&rft_id=info:doi/10.5152/eurasianjmed.2015.0087&rft_dat=%3Cproquest_pubme%3E1777488022%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875374272&rft_id=info:pmid/27026762&rfr_iscdi=true |